Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
6,991,674
-
Share change
-
-259,467
-
Total reported value
-
$27,267,000
-
Price per share
-
$3.90
-
Number of holders
-
11
-
Value change
-
-$4,556,476
-
Number of buys
-
3
-
Number of sells
-
9
Institutional Holders of AURIS MED HLDG AG - COM (EARS) as of Q4 2014
As of 31 Dec 2014,
AURIS MED HLDG AG - COM (EARS) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,991,674 shares.
The largest 10 holders included
Adamant Biomedical Investments AG, CLIFTON PARK CAPITAL MANAGEMENT, LLC, FMR LLC, RA CAPITAL MANAGEMENT, LLC, Clough Capital Partners L P, Alyeska Investment Group, L.P., Spark Investment Management LLC, GOLDMAN SACHS GROUP INC, ROYAL BANK OF CANADA, and DEUTSCHE BANK AG\.
This page lists
11
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.